Style | Citing Format |
---|---|
MLA | Nezamabadi SS, et al.. "Exploring Cd19-Targeted Immunotherapy Strategies for Human B-Cell Lymphoma." Archives of Razi Institute, vol. 80, no. 2, 2025, pp. 401-412. |
APA | Nezamabadi SS, Sabet AS, Peighambardoust SS, Behrouzieh S, Banihashemi SR, Amanpour S (2025). Exploring Cd19-Targeted Immunotherapy Strategies for Human B-Cell Lymphoma. Archives of Razi Institute, 80(2), 401-412. |
Chicago | Nezamabadi SS, Sabet AS, Peighambardoust SS, Behrouzieh S, Banihashemi SR, Amanpour S. "Exploring Cd19-Targeted Immunotherapy Strategies for Human B-Cell Lymphoma." Archives of Razi Institute 80, no. 2 (2025): 401-412. |
Harvard | Nezamabadi SS et al. (2025) 'Exploring Cd19-Targeted Immunotherapy Strategies for Human B-Cell Lymphoma', Archives of Razi Institute, 80(2), pp. 401-412. |
Vancouver | Nezamabadi SS, Sabet AS, Peighambardoust SS, Behrouzieh S, Banihashemi SR, Amanpour S. Exploring Cd19-Targeted Immunotherapy Strategies for Human B-Cell Lymphoma. Archives of Razi Institute. 2025;80(2):401-412. |
BibTex | @article{ author = {Nezamabadi SS and Sabet AS and Peighambardoust SS and Behrouzieh S and Banihashemi SR and Amanpour S}, title = {Exploring Cd19-Targeted Immunotherapy Strategies for Human B-Cell Lymphoma}, journal = {Archives of Razi Institute}, volume = {80}, number = {2}, pages = {401-412}, year = {2025} } |
RIS | TY - JOUR AU - Nezamabadi SS AU - Sabet AS AU - Peighambardoust SS AU - Behrouzieh S AU - Banihashemi SR AU - Amanpour S TI - Exploring Cd19-Targeted Immunotherapy Strategies for Human B-Cell Lymphoma JO - Archives of Razi Institute VL - 80 IS - 2 SP - 401 EP - 412 PY - 2025 ER - |